Chetan K. Kajavadara , Darshan T. Valani , Satyam N. Patel , Rushikesh M. Shukla , Laxit K. Bhatt , Rajesh J. Patel, Sunny P. Kumar, Rajesh Sundar, Mukul R. Jain
{"title":"Strain-specific mutagenicity of NDMA and CPNP: insights from TA1535, TA100, and WP2 uvrA (pKM101) under metabolic activation","authors":"Chetan K. Kajavadara , Darshan T. Valani , Satyam N. Patel , Rushikesh M. Shukla , Laxit K. Bhatt , Rajesh J. Patel, Sunny P. Kumar, Rajesh Sundar, Mukul R. Jain","doi":"10.1016/j.etap.2025.104752","DOIUrl":null,"url":null,"abstract":"<div><div>The Ames test is a critical assay for assessing the mutagenic potential of chemical compounds; however, its conventional version (OECD TG 471) falls short in detecting nitrosamine mutagenicity due to insufficient metabolic activation. Given the ubiquity of nitrosamines as environmental contaminants and drug impurities, an enhanced protocol incorporating 30 % v/v hamster and rat liver S9 fractions with a 30-minute pre-incubation is warranted. This study streamlined the enhanced Ames test by evaluating the sensitivity of <em>S. typhimurium</em> strains TA1535 and TA100, and <em>E. coli</em> WP2 <em>uvr</em>A (pKM101), against N‑nitrosodimethylamine (NDMA) and 1‑cyclopentyl‑4‑nitrosopiperazine (CPNP). Dose‑normalized fold‑induction metrics revealed that TA1535 offers superior sensitivity across varied S9 conditions. Hamster liver S9 generally enhanced mutagenic responses compared to rat liver S9. Notably, CPNP was more potent in TA1535 and TA100, while NDMA was more active in WP2 <em>uvr</em>A (pKM101) with rat S9. This optimized screening strategy minimizes resources and is recommended for initial nitrosamine impurity mutagenicity detection.</div></div>","PeriodicalId":11775,"journal":{"name":"Environmental toxicology and pharmacology","volume":"117 ","pages":"Article 104752"},"PeriodicalIF":4.2000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental toxicology and pharmacology","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1382668925001279","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
The Ames test is a critical assay for assessing the mutagenic potential of chemical compounds; however, its conventional version (OECD TG 471) falls short in detecting nitrosamine mutagenicity due to insufficient metabolic activation. Given the ubiquity of nitrosamines as environmental contaminants and drug impurities, an enhanced protocol incorporating 30 % v/v hamster and rat liver S9 fractions with a 30-minute pre-incubation is warranted. This study streamlined the enhanced Ames test by evaluating the sensitivity of S. typhimurium strains TA1535 and TA100, and E. coli WP2 uvrA (pKM101), against N‑nitrosodimethylamine (NDMA) and 1‑cyclopentyl‑4‑nitrosopiperazine (CPNP). Dose‑normalized fold‑induction metrics revealed that TA1535 offers superior sensitivity across varied S9 conditions. Hamster liver S9 generally enhanced mutagenic responses compared to rat liver S9. Notably, CPNP was more potent in TA1535 and TA100, while NDMA was more active in WP2 uvrA (pKM101) with rat S9. This optimized screening strategy minimizes resources and is recommended for initial nitrosamine impurity mutagenicity detection.
期刊介绍:
Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.
Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.
In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.